5.2
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
5.3
Impact Factor
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
Search in posts
Search in pages
Filter by Categories
Corrigendum
Current Issue
Editorial
Erratum
Full Length Article
Full lenth article
Letter to Editor
Original Article
Research article
Retraction
Retraction notice
Review
Review Article
SPECIAL ISSUE: ENVIRONMENTAL CHEMISTRY
View/Download PDF

Translate this page into:

Original article
12 (
5
); 671-679
doi:
10.1016/j.arabjc.2016.04.016

Ultrasound mediated green synthesis of pyrano[2,3-c]pyrazoles by using Mn doped ZrO2

School of Chemistry & Physics, University of KwaZulu-Natal, Westville Campus, Chilten Hills, Private Bag 54001, Durban 4000, South Africa
Discipline of Biochemistry, University of KwaZulu-Natal, Chiltern Hills, Durban 4000, South Africa
Department of Chemistry, Annamacharya Institute of Technology & Sciences, J.N.T.University, Tirupati 517 502, Andhra Pradesh, India

⁎Corresponding author. Tel.: +91 9441300060; fax: +91 877 2248909. gajulapallilavanya@gmail.com (Palakondu Lavanya)

Disclaimer:
This article was originally published by Elsevier and was migrated to Scientific Scholar after the change of Publisher.

Peer review under responsibility of King Saud University.

Abstract

Mn doped zirconia is utilized as an environmental-friendly and efficient catalyst for an ultrasound mediated four-component coupling reaction, containing dimethylacetylenedicarboxylate/ethyl acetoacetate, hydrazine hydrate, malononitrile, and aromatic aldehyde. These reactions were performed under green solvent conditions, to yield pyrano[2,3-c]pyrazole-3-carboxylate/pyrano[2,3-c]pyrazole-5-carbonitrile derivatives (5ag and 7ag) with good to excellent yields (88–98%). The structures of the compounds were identified and confirmed by 1H NMR, 15N NMR, 13C NMR, FT-IR and HR-MS spectral data. The prepared catalyst Mn/ZrO2 was synthesized and fully characterized by various techniques including P-XRD, BET, SEM and TEM analysis. The main benefits of this process are short reaction times, easy work-up, reusability of the catalyst and no chromatographic purifications.

Keywords

Ultrasound
Green synthesis
Multicomponent reaction
Pyrazoles
Heterogeneous catalyst
Reusability
1

1 Introduction

A major challenge faced by chemical and pharmaceutical industries is the improvement of supportable manufacturing procedures to synthesize targeted compounds in an energy-efficient and cost-effective benign manner (Doble and Kumar, 2007). In this regard, ultrasound irradiation has been acknowledged as an important technique to achieving green synthetic procedures. This technique can be an auspicious alternative for modern heterocyclic synthesis. Several ultra-sonication induced organic transformations offer additional accessibility in the field of synthetic heterocyclic chemistry due to the phenomena of cavitation. Cavitation is a physical process that creates, enlarges, and implodes gaseous and vaporous cavities in an irradiated liquid, thus enhancing the mass transfer and allowing chemical reactions to occur (Asakura et al., 2008). Among other techniques, this method gives higher yields in shorter reaction times and under mild reaction conditions (Vallin et al., 2002; Kappe, 2004). Therefore, ultrasonic irradiation is an important technique in heterocyclic synthesis.

The improvement of simple, efficient, and environmentally-benign technique for the synthesis of organic compounds from readily available reagents is an important challenge for scientists (Polshettiwar and Varma, 2008a). A multicomponent reaction (MCR) is a one-pot reaction in which three or more reactants are combined together to generate the desired product, without the isolation of any intermediate. This process is cost-effective, energy saving, lower reaction time and raw materials (Gawande et al., 2013). MCRs have proved very powerful and efficient bond-forming technique in heterocyclic and medicinal chemistry in the context of green chemistry (Polshettiwar and Varma, 2008a; Gawande et al., 2013; Domling, 2006). MCRs are very flexible, atom economic in nature, and proceed through a sequence of reaction equilibria, producing high yields of the targeted product (Domling, 2006; Devi and Bhuyan, 2004; Polshettiwar and Varma, 2008b). Among other reaction parameters, the nature of the catalyst is highly important in determining yield and selectivity (Domling, 2006; Devi and Bhuyan, 2004; Polshettiwar and Varma, 2008b). Hence, development of inexpensive, mild, reusable, and general catalysts for MCRs remains an issue of interest, thus, still in demand.

One of the promising approaches to “green chemistry” is to replace conservative procedures employing toxic and/or hazardous reagents with atom-efficient catalytic alternatives (Anastas and Kirchhoff, 2002). Most of the chemical reactions are time consuming; therefore, catalysts are generally used to speed up the reaction. Heterogeneous catalysts play a significant role in the modern industrial scenario because of their significant benefits in terms of easier product recovery, minimizing disposal problems, regeneration of active sites and environmental perspectives (Polshettiwar and Varma, 2010; Sheldon, 2005). In particular, heterogeneous catalysts, such as zirconia, offer many benefits such as thermal stability, long life, recyclability and high selectivity (Mizuno and Misono, 1998; Zhan-Hui and Tong-Shuang, 2009; Li-Ping and Zhan-Hui, 2011). Moreover, heterogeneous catalysts have also attracted much attention in heterocyclic synthesis because of numerous advantages which include easy handling, environmental compatibility, non-corrosiveness, saving energy, and ease of product separation. Furthermore, the re-usability of heterogeneous catalysts is one of the crucial principles of green chemistry.

Heterocyclic moieties make up a tremendously important class of compounds and have great value in many applications such as, medicinal, pharmaceutical, agrochemical, functional materials, among many others (Van Dijk et al., 2009). Among them, pyrazoles annulated heterocyclic derivatives represent an important class of N-containing heterocycles being the main components of many naturally occurring products (Dastan et al., 2012). Pyrazole derivatives have occupied a vital place in drug research because of their various biological and pharmacological activities such as antibacterial (Tanitame et al., 2004), antifungal (Ragavan et al., 2010), antioxidant (Daiane et al., 2014), anticancer (Kumar et al., 2013a,b), antileishmanial (Faria et al., 2013), hypotensive (Arya et al., 1969), and antiallergenic (Parsia et al., 1981) activities. Subsequently, several reports for the synthesis of these compounds have been reported including the use of TEA (Litvinov et al., 2009), Per-6-ABCD (Kuppusamy and Kasi, 2010), [(CH2)4SO3HMIM][HSO4] (Javad et al., 2012), TEABr (Kumar et al., 2013a), [Dsim]AlCl4 (Ahmad et al., 2013), FeNi3/SiO2/HPGMNP (Mohammad and Seyed, 2013), NaOH/microwave (Kathrotiya and Patel, 2012), Δ/reflux (Zonouz et al., 2012), Δ/CH3COOH (Gein et al., 2014), UV (Zou et al., 2011), Microwave (Sharma et al., 2016), Meglumine (Guo et al., 2013), S-proline (Khoobi et al., 2015), ZrO2 (Saha et al., 2015), Fe3O4@SiO2 (Soleimani et al., 2015), 1-(carboxymethyl)pyridinium iodide {[cmpy]I} (Moosavi-Zare et al., 2016), choline chloride/urea (Zonouz and Moghani, 2016), ZrO2 nanoparticle (Bodhak et al., 2015) and SnO2 (Paul et al., 2014). Several of these methods face few or more limitations such as, using expensive reagents and catalysts, strong acidic or basic conditions, toxic reagents, tedious steps, strict reaction conditions, low product yields and long reaction times, which limit their use in practical applications. All of these disadvantages make further improvement of the synthesis of such molecules essential. Therefore, the development of new greener, high-yielding, and environmentally-benign approaches is still desirable and much in demand.

In continuation of our previous research toward the improvement of new green routes for the synthesis of heterocyclic compounds using reusable catalysts (Maddila and Jonnalagadda, 2012a,b, 2013b; Maddila et al., 2013a, 2015a,b,c, 2016a,b), we report herein, the application of a novel recyclable heterogeneous solid catalyst (Mn supported zirconium (Mn/ZrO2)) under ultra-sonication for efficient, convenient and facile green synthesis of various pyranopyrazole derivatives through the one-pot reaction of dimethyl acetylenedicarboxylate (or) ethyl acetoacetate, hydrazine hydrate, malononitrile and aldehyde under aqueous ethanol solvent condition and at room temperature. In addition, to the best of our knowledge, there are no reports on the use of Mn supported ZrO2 as a heterogeneous catalyst under ultra-sonication for this conversion.

2

2 Materials and methods

2.1

2.1 Preparation of catalyst

Manganese oxide loaded on zirconia (1, 2 & 4 wt% Mn/ZrO2) catalysts was prepared by wet impregnation method (Chetty et al., 2012a,b). Typically, an appropriate wt% amount of manganese nitrate [Mn(NO3)2 (Alfa Aesar)] solution was added to 2.0 g of support (ZrO2, Catalyst support, Alfa Aesar) and the mixture was stirred at 40 °C for 8 h. Then the catalyst was dried in an oven at 110–130 °C for 12 h, followed by their calcination in the presence of air, at 450 °C for 3 h to acquire the w/w catalyst. The catalyst characterization details are provided in Electronic Supporting Information (ESI-I).

2.2

2.2 General procedure for the synthesis of pyrano[2,3-c]pyrazole-3-carboxylate and pyrano[2,3-c]pyrazole-5-carbonitrile derivatives under silent conditions

A flask containing a mixture of malononitrile (1 mmol), aromatic aldehyde (1 mmol), dimethylacetylenedicarboxylate/ethyl acetoacetate (1 mmol), hydrazine hydrate (1 mmol) and 2% Mn/ZrO2 (30 mg) in aqueous ethanol (1:1, v/v 10 mL) was employed and stirred at RT. The progress of the reaction was monitored by TLC. After completion of the reaction, the catalyst was filtered, and the solvent was evaporated to obtain the pure product (Scheme 1) without further recrystallization.

Synthesis of pyrano[2,3-c]pyrazoles-3-carboxylate derivatives.
Scheme 1 Synthesis of pyrano[2,3-c]pyrazoles-3-carboxylate derivatives.

2.3

2.3 General procedure for the synthesis of pyrano[2,3-c]pyrazole-3-carboxylate and pyrano[2,3-c]pyrazole-5-carbonitrile derivatives under ultrasound irradiation

A mixture of dimethylacetylenedicarboxylate/ethyl acetoacetate (1 mmol), hydrazine hydrate (1 mmol), malononitrile (1 mmol), aromatic aldehyde (1 mmol) and 2% Mn/ZrO2 (30 mg) in aqueous ethanol (1:1, v/v 10 mL) was irradiated with ultrasound at 40 kHz at room temperature within 10 min. After completion of the reaction as observed by TLC, the solution was filtered to separate the catalyst. The filtrate was concentrated under reduced pressure to afford the pure product. The structures of the resulting products were established on the basis of their physical properties and spectral data.

2.4

2.4 Physical data for the pyrano[2,3-c]pyrazole-3-carboxylate derivatives (5a–g)

2.4.1

2.4.1 6-Amino-5-cyano-4-(2,3-dimethoxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5a)

1H NMR (400 MHz, DMSO-d6): δ 3.55 (s, 3H, OCH3), 3.61 (s, 3H, OCH3), 3.77 (s, 3H, OCH3), 4.91 (s, 1H, CH), 6.60 (d, J = 7.08 Hz, 1H, ArH), 6.68 (d, J = 7.08 Hz, 1H, ArH), 6.93 (s, 2H, NH2), 6.95 (d, J = 8 Hz, 1H, ArH), 13.58 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 32.71 (CH), 51.59 (CH3 ester), 55.48 (OCH3), 56.86 (OCH3), 59.70 (C—CN), 104.21 (C), 114.45, 120.53 (CN), 121.24, 123.23, 128.45, 137.25, 146.39, 152.25 (C⚌O), 158.46 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 74.3; FT-IR: 3426, 3289, 3154, 2186, 1732, 1606, 1479, 1396, 1266; HRMS of [C17H16N4O5 − H] (m/z): 355.1042; Calcd: 355.1042.

2.4.2

2.4.2 6-Amino-5-cyano-4-(2-methoxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5b)

1H NMR (400 MHz, DMSO-d6): δ 3.58 (s, 3H, OCH3), 3.69 (s, 3H, OCH3), 5.01 (s, 1H, CH), 6.83 (d, J = 7.36 Hz, 1H, ArH), 6.86 (s, 2H, NH2), 6.92–6.95 (m, 2H, ArH), 7.17 (t, J = 7.32 Hz, 1H, ArH), 13.57 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 31.83 (CH), 51.56 (CH3 ester), 55.59 (OCH3), 56.63 (C—CN), 104.11, 111.50, 120.24 (CN), 120.34, 127.92, 129.00, 132.32, 156.67, 158.51 (C⚌O), 160.69 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 73.3; FT-IR: 3386, 3321, 3202, 2196, 1715, 1652, 1467, 1247; HRMS of [C16H14N4O4 − H] (m/z): 325.0929; Calcd: 325.0937.

2.4.3

2.4.3 6-Amino-5-cyano-4-(4-bromoxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5c)

1H NMR (400 MHz, DMSO-d6): δ 3.64 (s, 3H, OCH3), 4.75 (s, 1H, CH), 7.08 (s, 2H, NH2), 7.47 (d, J = 8.28 Hz, 2H, ArH), 7.72 (d, J = 8.36 Hz, 1H, ArH), 7.82 (d, J = 8.48 Hz, 1H, ArH), 13.77 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 32.23 (CH), 51.62 (CH3 ester), 56.28 (C—CN), 103.35, 109.77, 115.35, 119.45 (CN), 122.00, 133.56, 151.11, 156.47 (C⚌O), 160.74 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 75.8; FT-IR: 3293, 3155, 2196, 1739, 1637, 1449, 1397, 1227; HRMS of [C15H11BrN4O3 − H] (m/z): 372.9942; Calcd: 372.9936.

2.4.4

2.4.4 6-Amino-5-cyano-4-(2,4,6-trimethoxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5d)

1H NMR (400 MHz, DMSO-d6): δ 3.59 (s, 3H, OCH3), 3.73 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 5.27 (s, 1H, CH), 6.29 (s, 2H, ArH), 6.69 (s, 2H, NH2), 13.29 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 25.39 (CH), 51.50 (CH3 ester), 55.01 (OCH3), 55.42 (OCH3), 55.63 (OCH3), 91.07 (C—CN), 112.27 (CN), 154.35, 159.53, 160.57 (C⚌O), 161.22 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 71.3; FT-IR: 3430, 3322, 3202, 2189, 1713, 1596, 1397, 1227; HRMS of [C18H18N4O6 − H] (m/z): 385.1161; Calcd: 385.1148.

2.4.5

2.4.5 6-Amino-5-cyano-4-(3-hydroxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5e)

1H NMR (400 MHz, DMSO-d6): 3.61 (s, 3H, OCH3), 4.63 (s, 1H, CH), 6.53 (s, 1H, ArH), 6.59–6.62 (m, 2H, ArH), 6.83 (s, 2H, NH2), 7.10 (t, J = 7.8 Hz, 1H, ArH), 9.31 (s,1H, OH), 13.24 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 36.14 (CH), 57.26 (CH3 ester), 97.66 (C—CN), 113.80, 114.10, 118.15, 120.77 (CN), 129.23, 135.53, 145.93, 154.39, 157.39 (C⚌O), 160.80 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 75.3; FT-IR: 3422, 3178, 2188, 1712, 1633, 1490, 1397, 1207; HRMS of [C15H12N4O4 − H] (m/z): 311.0984; Calcd: 311.0988.

2.4.6

2.4.6 6-Amino-5-cyano-4-(2-fluorophenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5f)

1H NMR (400 MHz, DMSO-d6): δ 3.61 (s, 3H, OCH3), 5.01 (s, 1H, CH), 7.06 (s, 2H, NH2), 7.10–7.12 (m, 3H, ArH), 7.24 (t, J = 1.96 Hz, 1H, ArH), 13.76 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 31.13 (CH), 51.58 (CH3 ester), 56.08 (C—CN), 102.95, 124.32 (CN), 128.75, 129.99, 158.28 (C⚌O), 160.58 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 74.8; FT-IR: 3321, 3379, 3201, 2202, 1720, 1655, 1442, 1224; HRMS of [C15H11FN4O3 − H] (m/z): 313.0734; Calcd: 313.0737.

2.4.7

2.4.7 6-Amino-5-cyano-4-(2,5-dimethoxyphenyl)-2,4-dihydropyrano[2,3-c]pyrazole-3-carboxylate (5g)

1H NMR (400 MHz, DMSO-d6): δ 3.64 (s, 3H, OCH3), 3.76 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 4.95 (s, 1H, CH), 6.89 (s, 2H, NH2), 7.09 (d, J = 1.2 Hz, 2H, ArH), 7.49 (s, 1H, ArH), 13.54 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 32.45 (CH), 51.62 (CH3 ester), 55.44 (OCH3), 56.28 (OCH3), 56.46 (C—CN), 109.7, 111.81, 115.35, 119.45, 120.38 (CN), 122.00, 133.56, 151.04, 153.33, 158.49 (C⚌O), 160.74 (C—NH2); 15N NMR (40.55 MHz, DMSO-d6): δ 72.8; FT-IR: 3531, 3375, 3194, 2939, 2202, 1713, 1600, 1492, 1221. HRMS of [C17H16N4O5 − H] (m/z): 355.0844; Calcd: 355.0838.

2.5

2.5 Physical data for the pyrano[2,3-c]pyrazole-5-carbonitrile derivatives (7a–g)

2.5.1

2.5.1 6-Amino-4-(2,3-dimethoxyphenyl)-3-methyl-2,4-dihydro-pyrano[2,3-c]pyrazole-5-carbonitrile (7a)

1H NMR (400 MHz, DMSO-d6) δ = 1.76 (s, 3H, CH3), 3.64 (s, 3H, OCH3), 3.79 (s, 3H, OCH3), 4.82 (s, 1H, CH), 6.59 (dd, J = 7.52 Hz, 1.28 Hz, 1H, ArH), 6.80 (s, 2H, NH2), 6.89 (d, J = 6.8 Hz, 1H, ArH), 6.99 (t, J = 7.96 Hz, 1H, ArH), 11.99 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 161.12 (C—NH2), 154.95, 152.15, 146.19, 137.29, 135.09, 123.98, 120.97, 120.72, 111.06, 97.75, 60.22 (C—CN), 56.66 (OCH3), 55.48 (OCH3), 30.32 (CH), 9.42 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 76.2; FT-IR (KBr, cm−1): 3375, 3113, 2972, 2186, 1638, 1519, 1475, 1395; HRMS of [C16H16N4O3 − H]+ (m/z): 311.1139; Calcd: 311.1144.

2.5.2

2.5.2 6-Amino-4-(2-methoxyphenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]pyrazole-5-carbonitrile (7b)

1H NMR (400 MHz, DMSO-d6) δ = 1.78 (s, 3H, CH3), 3.77 (s, 3H, OCH3), 4.96 (s, 1H, CH), 6.78 (s, 2H, NH2), 6.89 (t, J = 14.68 Hz, 1H, ArH), 6.98 (t, J = 7.56 Hz, 2H, ArH), 7.17–7.21 (m, 1H, ArH), 12.00 (s, 1H, NH). 13C NMR (100 MHz, DMSO-d6): 161.43 (C—NH2), 156.31, 155.02, 135.03, 132.06, 128.57, 127.88, 120.85, 120.77, 111.26, 97.87, 56.34 (C—CN), 55.53 (OCH3), 29.11 (CH), 9.45 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 72.5; FT-IR (KBr, cm−1): 3374, 3338, 3154, 2837, 2194, 1655, 1595, 1486, 1463, 1241; HRMS of [C15H14N4O2 − H]+ (m/z): 281.1040; Calcd: 281.1039.

2.5.3

2.5.3 6-Amino-4-(4-bromophenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]pyrazole-5-carbonitrile (7c)

1H NMR (400 MHz, DMSO-d6) δ = 1.79 (s, 3H, CH3), 4.61 (s, 1H, CH), 6.91 (s, 2H, NH2), 7.13 (d, J = 8.4 Hz, 2H, ArH), 7.50 (d, J = 8.32 Hz, 2H, ArH), 12.12 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 160.88 (C—NH2), 143.86, 135.65, 131.34, 129.70, 126.90, 120.59, 119.72, 97.09, 56.68 (C—CN), 35.60 (CH), 9.70 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 73.7; FT-IR (KBr, cm−1): 3141, 2180, 1646, 1596, 1484, 1221, 1162; HRMS of [C14H11BrN4O − 2H]+ (m/z): 328.0929; Calcd: 328.0937.

2.5.4

2.5.4 6-Amino-4-(2,4,6-trimethoxyphenyl)-3-methyl-2,4-dihydro-pyrano[2,3-c]pyrazole-5-carbonitrile (7d)

1H NMR (400 MHz, DMSO-d6) δ = 1.79 (s, 3H, CH3), 3.73 (s, 3H, OCH3), 3.81 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 5.12 (s, 1H, CH), 6.29 (s, 2H, ArH), 6.69 (s, 2H, NH2), 12.29 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 161.22 (C—NH2), 130.57, 159.53, 154.34, 112.27, 91.07, 55.93 (C—CN), 55.63 (OCH3), 55.42 (OCH3), 55.01 (OCH3), 25.39 (CH), 9.66 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 74.7; FT-IR (KBr, cm−1): 3322, 3202, 2943, 2189, 1645, 1454, 1397, 1227. HRMS of [C15H11FN4O3 − H] (m/z): 313.0734; Calcd: 313.0737.

2.5.5

2.5.5 6-Amino-4-(3-hydroxyphenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]pyrazole-5-carbonitrile (7e)

1H NMR (400 MHz, DMSO-d6) δ = 1.81 (s, 3H, CH3), 4.48 (s, 1H, CH), 6.53 (s, 1H, ArH), 6.59–6.62 (m 2H, ArH), 6.83 (s, 2H, NH2), 7.09 (t, J = 7.8 Hz, 1H, ArH), 9.29 (s, 1H, OH), 12.07 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 160.80 (C—NH2), 157.39, 154.73, 145.93, 135.53, 129.23, 120.77, 118.15, 114.10, 113.80, 97.66, 57.26 (C—CN), 36.14 (CH), 9.73 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 74.9; FT-IR (KBr, cm−1): 3360, 3163, 2177, 1647, 1591, 1485, 1348, 1283; HRMS of [C14H12N4O2 − H]+ (m/z): 267.0878; Calcd: 267.0882.

2.5.6

2.5.6 6-Amino-4-(2-fluorophenyl)-3-methyl-2,4-dihydropyrano-[2,3-c]pyrazole-5-carbonitrile (7f)

1H NMR (400 MHz, DMSO-d6) δ = 1.80 (s, 3H, CH3), 4.86 (s, 1H, CH), 6.91 (s, 2H, NH2), 7.14–7.18 (m, 3H, ArH), 7.25–7.29 (m, 1H, ArH), 12.10 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 161.28 (C—NH2), 158.69, 154.87, 135.32, 130.76, 130.64, 129.80, 128.86, 128.78, 128.78, 124.68, 120.55, 115.59, 115.37, 96.59, 55.52 (C—CN), 30.02 (CH), 9.36 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 73.9; FT-IR (KBr, cm−1): 3385, 3164, 2189, 1651, 1595, 1484, 1406, 1256, 1209; HRMS of [C14H11N4OF − H]+ (m/z): 269.0835; Calcd: 269.0839.

2.5.7

2.5.7 6-Amino-4-(2,5-dimethoxyphenyl)-3-methyl-2,4-dihydro-pyrano[2,3-c]pyrazole-5-carbonitrile (7g)

1H NMR (400 MHz, DMSO-d6) δ = 1.81 (s, 3H, CH3), 3.76 (s, 3H, OCH3), 3.83 (s, 3H, OCH3), 4.95 (s, 1H, CH), 6.89 (s, 2H, NH2), 7.09 (d, J = 1.2 Hz, 2H, ArH), 7.49 (s, 1H, ArH), 12.09 (s, 1H, NH); 13C NMR (100 MHz, DMSO-d6): 160.74 (C—NH2), 156.47, 153.11, 152.64, 151.04, 133.56, 122.00, 119.45, 113.61, 112.84, 109.77, 103.92, 56.28 (C—CN), 55.44 (OCH3), 51.62 (OCH3), 31.03 (CH), 9.61 (CH3); 15N NMR (40.55 MHz, DMSO-d6): δ 72.3; FT-IR (KBr, cm−1): 3375, 3194, 2939, 2202, 1653, 1492, 1331, 1221. HRMS of [C16H16N4O3 − H]+ (m/z): 311.0984; Calcd: 311.0988.

3

3 Results and discussion

3.1

3.1 Nitrogen adsorption analysis

The N2 adsorption/desorption isotherms and corresponding pore size distribution of the Mn doped zirconia catalyst are shown in Fig. 1. The isotherm is a typical type IV isotherm with the presence of a hysteresis loop (H2 type), which indicates the presence of mesopores in the material. The pore size distribution and specific area were calculated from the Barrett–Joyner–Halenda (BJH adsorption) and Brunauer–Emmett–Teller methods, respectively. The BET surface area calculated from this isotherm is 194.56 m2 g−1. The pore volume estimated for this sample is 0.563 cm3 g−1.

N2 adsorption and desorption spectra of 2% Mn/ZrO2 catalyst.
Figure 1 N2 adsorption and desorption spectra of 2% Mn/ZrO2 catalyst.

3.2

3.2 Powder X-ray diffraction analysis

An X-ray diffractogram of the calcined prepared Mn/ZrO2 catalyst is depicted in Fig. 2. The narrow line widths indicate a high crystallinity of the material. ZrO2 displayed diffraction peaks at 2θ = 28.45, 31.53, 35.25, 50.55 and 60.23 corresponding to (1 1 1), (0 0 2), (0 2 2), (1 1 3) planes representing various phases. The d-spacings at 2θ peaks of 25.27, 34.79, 38.83, 55.21, and 66.12 for Mn2O3 respectively. It is in good agreement with the JCPDS file no. 41-1442. From the XRD image it is evident that Mn2O3 is the major phase in this catalyst. There is a formation of other phase, i.e. Mn3O4 observed. The d-spacings at 2θ angles of 16.02, 26.17, 33.12, 45.47, 49.88 and 57.73 for Mn3O4 correspond to the JCPDS file no. 18-0803 for Mn3O4 phase.

XRD spectrum of 2% Mn/ZrO2 catalyst.
Figure 2 XRD spectrum of 2% Mn/ZrO2 catalyst.

3.3

3.3 TEM analysis

The size and morphology of Mn doped ZrO2 were analyzed by transmission electron microscopy (TEM) (Fig. 3). The result shows that the catalyst consists of spherical particles with the crystallite size between 12 and 23 nm for manganese oxide particles which could be agglomerated on the zirconia surface. Due to the relatively low doping of Mn, we did not observe many MnO2 particles. The image revealed that the ZrO2 existed as uneven elliptical shaped particles.

TEM micrograph of 2% Mn/ZrO2 catalyst.
Figure 3 TEM micrograph of 2% Mn/ZrO2 catalyst.

3.4

3.4 SEM analysis

Fig. 4 reveals the SEM images of MnO2 doped ZrO2 catalyst. MnO2 particles were observed as tiny particles homogeneously distributed on the surface of ZrO2. The manganese oxide particles are evidenced as hexagonally shaped. The catalyst appeared crystalline in nature. Due to the low loading of manganese there were a low number of particles observed. The SEM–EDX confirms the data from ICP elemental analysis. Furthermore, the morphology of the catalyst from the SEM images noticeably points to the crystallinity and homogeneity of the sample.

SEM micrograph of 2% Mn/ZrO2 catalyst.
Figure 4 SEM micrograph of 2% Mn/ZrO2 catalyst.

3.5

3.5 Optimization procedure

In order to synthesize pyranopyrazole derivatives, we have examined the multicomponent reaction of dimethylacetylenedicarboxylate/ethyl acetoacetate (1 mmol), hydrazine hydrate (1 mmol), malononitrile (1 mmol) and aromatic aldehyde (1 mmol) in aqueous ethanol (1:1, v/v) in the presence of catalytic amount of 2% Mn/ZrO2 (30 mg) by using ultrasound irradiation at room temperature (Scheme 1).

Firstly, the effect of various solvents (non-polar, protic and aprotic) on the formation of pyranopyrazoles was investigated in the presence of catalyst under silent and ultrasonification (Table 1). Under solvent free conditions, the reaction did not take place, even in the presence of catalyst at prolonged reaction time (Table 1, entry 1). In non-polar solvents such as 1,4-dioxane, n-hexane and toluene, the reaction did not proceed (Table 1, entries 2–4). Further, low yields were obtained using polar aprotic solvents such as THF, and DMF (Table 1, entries 5 and 6). In the case of polar protic solvents such as methanol, ethanol and water (Table 1, entries 7–9), the yield of the desired products was good; however, an excellent yield was afforded using H2O and EtOH (1:1, v/v) as the solvent (Table 1, entry 10). The efficiency of methanol and ethanol relative to water was also investigated. Although comparable yields were observed (Table 1), aqueous ethanol had a marginal advantage, thus proving to be best medium for the reaction. A highly polar solvent which dissipates heat faster may provide optimum conditions for the formation of intermediates, and their conversion to final products on the catalyst surface. Therefore, the reaction was optimized using a cheap, safe, and environmentally benign reaction medium as opposed to the other synthetic solvents. An aqueous ethanol could also be used as the best solvent for the synthesis.

Table 1 Optimization of various solvents for the synthesis of 5a by 2% Mn/ZrO2 catalyst.
Entry Solvent Conventionalc Sonicationc
Time (h) Yielda (%) Time (h) Yielda (%)
1 No solvent 24 b 2 b
2 1,4-Dioxane 12 b 2 b
3 n-Hexane 12 b 2 b
4 Toluene 12 b 2 b
5 THF 8.0 15 1.5 21
6 DMF 7.5 12 2.0 33
7 MeOH 5.5 59 0.5 88
8 EtOH 4.0 67 0.2 90
9 H2O 5.0 63 0.3 89
10 EtOH:H2O (1:1) 1.0 88 0.1 98
Isolated yields.
Products were not found.
Room temperature.

Next, the model reaction for the synthesis of pyranopyrazoles was carried out in the absence and presence of different catalysts at different reaction temperature under magnetic stirring and ultrasonication by using aqueous ethanol as solvent (Table 2). When, the reaction neither at room temperature nor at heating condition proceeds even for a prolonged reaction time without catalyst (Table 2, entries 1 and 2). This indicates that the catalyst is necessary for this conversion. However, the starting materials were screened by different acidic catalysts such as FeCl2 and ZnCl2 at RT in aqueous ethanolic media and gave trace yields under both conditions, with the product yield obtained in less reaction time using ultrasonication (Table 2, entries 3 and 4). Further, the reaction was performed using the organic and inorganic bases such as Et3N, NaOH, K2CO3, and Na2CO3. In the presence of these bases after 3 h, only low amount of the product was observed under silent conditions. The yield of the product was considerably increased within shorter reaction time under ultrasound irradiation (Table 2, entries 5–8). Thereafter, the reaction was performed in the presence of an ionic liquid like (Bmim)BF4 to obtain moderate yields at RT condition, but the product was obtained at 1.5 h under ultrasound irradiation (Table 2, entry 9). Further heterogeneous pure oxides, such as Al2O3, SiO2 and ZrO2 were employed as catalysts under both conditions. The reaction gave moderate to good yields and reduced the reaction times. Fascinatingly, by using the ZrO2 as catalyst, an ample improvement in yield was observed (Table 1, entries 10–12). Based on the positive results obtained with zirconia, reactivity for various metal supported ZrO2 catalysts, such as 2% Ag/ZrO2 and 2% Mn/ZrO2 was screened. These mixed oxide catalyzed reactions gave improved yields (78% and 83%) within 1.0 h reaction time under normal condition and yields (85% and 98%) within 10 min reaction time under ultrasonication (Table 1, entries 13 and 14). Tremendously, when Mn supported on ZrO2 was used as catalyst, the reaction progressed impressively recording an excellent 98% yield of pyranopyrazoles at RT within 10 min reaction time under ultrasonication (Table 2, entry 14). This study endorses that ultrasonication method with aqueous ethanol as solvent media is the best for one-pot, four-component reactions to achieve excellent yields.

Table 2 Optimal condition for the synthesis of 5a by 2% Mn/ZrO2 catalyst.a
Entry Catalyst Condition Conventional Sonication
Time (h) Yieldb (%) Time (h) Yieldb (%)
1 No catalyst RT 12 5.0
2 No catalyst 50 °C 12 5.0
3 FeCl2 RT 8 Trace 3.5 Trace
4 ZnCl2 RT 7 Trace 4.0 Trace
5 Et3N RT 3.2 33 2.5 39
6 NaOH RT 3.5 26 2.0 33
7 K2CO3 RT 3.5 22 2.0 36
8 Na2CO3 RT 4.0 28 2.0 30
9 (Bmim)BF4 RT 3.0 48 1.5 53
10 Al2O3 RT 2.5 59 1.0 62
11 SiO2 RT 2.0 64 0.75 68
12 ZrO2 RT 1.5 73 0.50 76
13 2% Ag/ZrO2 RT 1.0 78 0.15 85
14 2% Mn/ZrO2 RT 1.0 83 0.10 98

– No reaction.

All products were characterized by IR, 1HNMR, 13C NMR, 15N NMR and HRMS spectral data.
Isolated yields.

It was perceived that the optimal the amount of catalyst loading in the synthesis of desired products, we started the study by treating a mixture of dimethylacetylenedicarboxylate/ethyl acetoacetate, hydrazine hydrate, malononitrile, and aromatic aldehyde in the presence of various amounts of Mn/ZrO2 catalyst in aqueous ethanol under ultrasonication to afford the target protocols. The results of this study are described in Table 3. It is noted that, when the amount of catalyst was lower, the yield of the product decreased, whereas raising the catalyst concentration did not lead to a pronounced increase in the product yield. During our optimization studies, 30 mg of 2% Mn doped ZrO2 gave the best result in terms of time of completion and the product was obtained in 98% yield (Table 3).

Table 3 Optimization of the amount of 2% Mn/ZrO2 as catalyst in the synthesis of 5aa.
Entry Catalyst amount (mg) Time (min) Yield (%)
1 10 30 85
2 20 20 88
3 30 10 98
4 40 10 95
5 50 15 95
Reaction conditions: malononitrile (1.1 mmol), aromatic aldehyde (1 mmol), dimethylacetylenedicarboxylate/ethyl acetoacetate (1 mmol), hydrazine hydrate (1 mmol), catalyst and aqueous ethanol (1:1, v/v 10 mL), RT.

To assess the versatility of this method a series of aromatic aldehydes were studied under the optimum reaction conditions; the results are listed in Table 4. In all cases, the reactions gave the products in good to excellent yields in very short reaction times. Fascinatingly, a variety of aryl aldehydes bearing both electron-releasing and electron-withdrawing (o, m and p functional) groups have apparently no obvious effect on the yields obtained and the reaction time under the optimal conditions, and afforded the pyrano[2,3-c]pyrazole-3-carboxylate/pyrano[2,3-c]pyrazole-5-carbonitrile derivatives (5ag and 7ag) in good to excellent yield in all the cases (Table 4). Structures of all the products (5ag and 7ag) were established and confirmed on the basis of their spectral data, 1H NMR, 13C NMR, 15N NMR (GHSQC) and HRMS.

Table 4 Synthesis of pyrano[2,3-c]pyrazole-3-carboxylate/pyrano[2,3-c]pyrazole-5-carbonitrile derivatives catalyzed by Mn/ZrO2.
Entry R Product Yield (%) Mp (°C) Lit Mp (°C)
1 2,3-(OMe)2 5a 97 224–225
2 2-OMe 5b 98 249–250
3 4-Br 5c 89 246–247 247–248 (Zonouz and Moghani, 2016)
4 2,4,6-(OMe)3 5d 93 238–239
5 3-OH 5e 90 217–219
6 2-F 5f 88 251–252
7 2,5-(OMe)2 5g 95 255–256
8 2,3-(OMe)2 7a 97 214–216
9 2-OMe 7b 98 253–254 252–253 (Mohammad and Seyed, 2013)
10 4-Br 7c 90 178–179
11 2,4,6-(OMe)3 7d 93 227–228
12 3-OH 7e 90 260–261
13 2-F 7f 89 259–260
14 2,5-(OMe)2 7g 95 212–213

– New compounds/no literature available.

According to our results, the probable mechanism to account for the reaction was suggested (Scheme 1). The reaction mechanism displays the tandem sequence of Mn/ZrO2 catalyzed through ultrasound irradiation reactions proposed to explain formation of the pyranopyrazoles. In the first step, 2-arylidenemalononitrile (3) is formed by a fast Knoevenagel condensation of malononitrile (1) with arylaldehyde (2) catalyzed by the Mn/ZrO2 under ultrasound irradiation. The second step involves formation of 1H-pyrazol-3-carboxylate (6) by reaction of hydrazine hydrate (5) with ester compound (4). In the third step, a Michael addition of 3–7 in the presence of the catalyst under ultrasound irradiation produces the intermediate. Intramolecular cyclization and subsequently tautomerization afford the desired pyranopyrazole derivatives.

3.6

3.6 Reusability of the catalyst

Recovery and reuse of catalysts is a significant facet of green chemistry and makes it useful for commercial applications. Thus, the reusability of the catalyst was tested in the synthesis of pyranopyrazoles. Excitingly, after each reaction, the catalyst was filtered and the recovered catalyst was washed with hot ethanol (2 × 10 mL), which was then dried at 110 °C under reduced pressure for 2–3 h. The recycled catalyst was used for the subsequent runs repeating the same procedure. The reusability of the catalyst was evaluated in the synthesis of pyrano[2,3-c]pyrazole-3-carboxylate/pyrano[2,3-c]pyrazole-5-carbonitrile derivatives (5ag and 7ag). The recovered catalyst was employed in six consecutive runs, and the decrease in activity was marginal (Fig. 5).

Recyclability of 2% Mn/ZrO2 catalyst.
Figure 5 Recyclability of 2% Mn/ZrO2 catalyst.

4

4 Conclusion

In this study, we report a rapid, clean and highly efficient approach for the synthesis of green, one-pot, four-component reactions catalyzed by Mn/ZrO2 under ultrasonication to obtain pyrano[2,3-c]pyrazole-3-carboxylate/pyrano[2,3-c]pyrazole-5-carbonitrile derivatives as the desired product in short time span and in quantitative yields by a simple and economical protocol. The catalyst is clean, safe, non-toxic inexpensive and it is easily prepared. This catalyst can be recovered easily and reused over several reaction cycles without substantial loss of reactivity. Overall the present approach is a facile, leading to higher yield of pyranopyrazole derivatives by a one-pot and four component reaction under ultrasound irradiation in aqueous ethanol at room temperature.

Acknowledgments

The authors are thankful to the authorities of the School of Chemistry & Physics, University of KwaZulu-Natal, Westville campus, Durban, South Africa, and Department of Chemistry, Annamacharya Institute of Technology & Sciences, Tirupati, India, for the facilities.

References

  1. , , , , , . New. J. Chem.. 2013;37:4089-4094.
  2. , , . Acc. Chem. Res.. 2002;35:686-694.
  3. , , , , , , . J. Pharma. Sci.. 1969;58:432-440.
  4. , , , , . Ultrason. Sonochem.. 2008;15:244-250.
  5. , , , . RSC Adv.. 2015;5:85202-85213.
  6. , , , , . ACS-Indu. Eng. Chem. Res.. 2012;51:2864-2873.
  7. , , , , . Appl. Catal. B: Environ.. 2012;117–118:18-28.
  8. , , , , , . Mini-Rev. Med. Chem.. 2014;14:1078-1092.
  9. , , , . Green Chem.. 2012;14:17-37.
  10. , , . Tetrahedron Lett.. 2004;45:8625-8627.
  11. , , . Green Chemistry and Engineering (first ed.). Amsterdam: Elsevier; .
  12. , . Chem. Rev.. 2006;106:17-89.
  13. , , , , , , , , . Bioorg. Med. Chem. Lett.. 2013;23:6310-6312.
  14. , , , , , . Chem. Soc. Rev.. 2013;42:5522-5551.
  15. , , , . Tetrahedron Lett.. 2014;55:4525-4528.
  16. , , , , , , , . Tetrahedron. 2013;69:9931-9938.
  17. , , , , , . J. Chem. Sci.. 2012;5:1013-1017.
  18. , . Angew. Chem. Int. Ed.. 2004;43:6250-6284.
  19. , , . J. Serb. Chem. Soc.. 2012;77:983-991.
  20. , , , , , , , , , , . Eur. J. Med. Chem.. 2015;89:296-303.
  21. , , , , , , . Org. Prep. Proc. Int.. 2013;45:429-436.
  22. , , , , . Eur. J. Med. Chem.. 2013;70:248-258.
  23. , , . Tetraheron Lett.. 2010;51:3312-3316.
  24. , , , . Rus. Chem. Bull. Int. Ed.. 2009;58:2362-2368.
  25. , , . Lett. Drug Des. Dis.. 2012;9:687-693.
  26. , , . Arch. Der Pharm. Life Sci.. 2012;345:163-168.
  27. , , , , , . Lett. Drug Des. Dis.. 2013;10:977-983.
  28. , , . Lett. Org. Chem.. 2013;10:374-379.
  29. , , , , . J. Heterocyc. Chem.. 2016;15:658-664.
  30. , , , , , . Catal. Commun.. 2015;61:26-30.
  31. , , , , . Res. Chem. Int.. 2015;41:8269-8278.
  32. , , , . J. Heterocyc. Chem.. 2015;52:487-499.
  33. , , , , . Chem. Open.. 2016;5:38-42.
  34. , , . Chem. Rev.. 1998;98:199-217.
  35. , , . Monatsh Chem.. 2013;144:1551-1558.
  36. , , , , . J. Mol. Catal. A: Chem.. 2016;415:144-150.
  37. , , , , , , , . J. Med. Chem.. 1981;24:117-119.
  38. , , , , , . Tetrahedron. 2014;70:6088-6099.
  39. , , . Acc. Chem. Res.. 2008;41:629-639.
  40. , , . Chem. Soc. Rev.. 2008;37:1546-1557.
  41. , , . Green Chem.. 2010;12:743-754.
  42. , , , . Eur. J. Med. Chem.. 2010;45:1173-1180.
  43. , , , . Green Chem.. 2015;17:2859-2866.
  44. , , , , , . Curr. Microwave Chem.. 2016;3:78-84.
  45. , . Green Chem.. 2005;7:267-278.
  46. , , , , , , , . J. Chin. Chem. Soc.. 2015;62:1155-1162.
  47. , , , , , , , , , , , , , . J. Med. Chem.. 2004;47:3693-3696.
  48. , , , , . J. Org. Chem.. 2002;67:6243-6246.
  49. , , , , , . Bioconjugate Chem.. 2009;20:2001-2016.
  50. , , . Curr. Org. Chem.. 2009;13:1-30.
  51. , , . Curr. Org. Chem.. 2011;15:3800-3823.
  52. , , , . Tetrahedron Lett.. 2012;53:5519-5522.
  53. , , . Syn. Commun.. 2016;46:220-225.
  54. , , , , , , , . Ultrasonics Sonochem.. 2011;18:708-712.

Appendix A

Supplementary material

Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.arabjc.2016.04.016.

Appendix A

Supplementary material

Supplementary data 1

Supplementary data 1

Show Sections